<?xml encoding="utf-8" ?> Editor’s note: This story and headline have been corrected to reflect that BNT122 is a BioNTech and ...

Since the early stages of the COVID-19 vaccine rollout in the U.S., vaccine skeptics have used outdated interviews to spread claims that executives are refusing shots developed by their own ...

CLAIM: Video shows that the CEO of BioNTech, Dr. Ugur Sahin, will not take the COVID-19 vaccine that his firm developed with Pfizer. THE FACTS: Social media posts are misrepresenting an interview that ...

He has conquered Covid for the time being, and now the CEO of BioNTech says he wants to turn his attention back to his first interest: cancer. Dr. Ugur Sahin is trying out the same mRNA technology ...

The move could further inflame a tortuous debate among scientists over when the coronavirus vaccines’ protection should be bolstered, and for whom. By Sharon LaFraniere WASHINGTON — Pfizer and ...

BERLIN, July 3 (Reuters) - BioNTech (22UAy.DE), opens new tab has held confidential talks with potential buyers ‌about German sites that the COVID‑19 vaccine maker plans to close, the Handelsblatt ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

The FDA granted Pfizer and BioNTech full U.S. approval of their Covid-19 vaccine. The move may encourage some unvaccinated Americans to get the shots as well as give more private businesses across the ...

PLEASE NOTEThe Washington Post is providing this news free to all readers as a public service. Follow this story and more by signing up for health, science, and environment email alerts. Federal ...

Since the early stages of the COVID-19 vaccine rollout in the U.S., vaccine skeptics have used outdated interviews to spread claims that executives are refusing shots developed by their own ...